Heliyon (Feb 2024)

Research progress on emulsion vaccine adjuvants

  • Zhuanqing Huang,
  • Hui Gong,
  • Qi Sun,
  • Jinjin Yang,
  • Xiaochuan Yan,
  • Fenghua Xu

Journal volume & issue
Vol. 10, no. 3
p. e24662

Abstract

Read online

Vaccination is the most cost-effective method for preventing various infectious diseases. Compared with conventional vaccines, new-generation vaccines, especially recombinant protein or synthetic peptide vaccines, are safer but less immunogenic than crude inactivated microbial vaccines. The immunogenicity of these vaccines can be enhanced using suitable adjuvants. This is the main reason why adjuvants are of great importance in vaccine development. Several novel human emulsion-based vaccine adjuvants (MF59, AS03) have been approved for clinical use. This paper reviews the research progress on emulsion-based adjuvants and focuses on their mechanism of action. An outlook can be provided for the development of emulsion-based vaccine adjuvants.

Keywords